Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV Infection
Syria Laperche(Établissement Français du Sang), Nicole Simon(Association pour l'Utilisation du Rein Artificiel), Françoise Bouchardeau(Institut National de la Transfusion Sanguine), M. Maniez-Montreuil(Établissement Français du Sang), Annabelle Servant‐Delmas(Institut National de la Transfusion Sanguine), Thierry Levayer(Établissement Français du Sang), Pascal Morel, A Girault(Institut National de la Transfusion Sanguine), Nadine Le Marrec(Institut National de la Transfusion Sanguine), Pierre Gallian(Établissement Français du Sang)
Cited by 115
Related Papers
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
|Science Immunology|2021|638
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
|Proceedings of the National Academy of Sciences|2022|198
Sensitivities of Four New Commercial Hepatitis B Virus Surface Antigen (HBsAg) Assays in Detection of HBsAg Mutant Forms
|Journal of Clinical Microbiology|2006|92
Advances in Human B19 Erythrovirus Biology
|Journal of Virology|2010|91